113 related articles for article (PubMed ID: 7968212)
1. A potential 5-HT1A receptor antagonist: p-MPPI.
Kung HF; Kung MP; Clarke W; Maayani S; Zhuang ZP
Life Sci; 1994; 55(19):1459-62. PubMed ID: 7968212
[TBL] [Abstract][Full Text] [Related]
2. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
Kung MP; Frederick D; Mu M; Zhuang ZP; Kung HF
J Pharmacol Exp Ther; 1995 Jan; 272(1):429-37. PubMed ID: 7815360
[TBL] [Abstract][Full Text] [Related]
3. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
4. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
Thielen RJ; Fangon NB; Frazer A
J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
[TBL] [Abstract][Full Text] [Related]
5. New 5-HT1A receptor antagonist: [3H]p-MPPF.
Kung HF; Stevenson DA; Zhuang ZP; Kung MP; Frederick D; Hurt SD
Synapse; 1996 Aug; 23(4):344-6. PubMed ID: 8855520
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
Kung MP; Zhuang ZP; Frederick D; Kung HF
Synapse; 1994 Dec; 18(4):359-66. PubMed ID: 7886629
[TBL] [Abstract][Full Text] [Related]
7. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
8. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Zhuang ZP; Kung MP; Mu M; Kung HF
J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
[TBL] [Abstract][Full Text] [Related]
9. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
10. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
11. Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands.
Zhuang ZP; Kung MP; Chumpradit S; Mu M; Kung HF
J Med Chem; 1994 Dec; 37(26):4572-5. PubMed ID: 7799409
[TBL] [Abstract][Full Text] [Related]
12. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
13. Effects of novel 5-HT1A receptor antagonists on measures of post-synaptic 5-HT1A receptor activation in vivo.
Thielen RJ; Frazer A
Life Sci; 1995; 56(7):PL163-8. PubMed ID: 7869825
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Oksenberg D; Peroutka SJ
Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
[TBL] [Abstract][Full Text] [Related]
15. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
De Vivo M; Maayani S
Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.
Zhuang ZP; Kung MP; Kung HF
J Med Chem; 1994 May; 37(10):1406-7. PubMed ID: 8182697
[No Abstract] [Full Text] [Related]
17. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
Assié MB; Cosi C; Koek W
Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
[TBL] [Abstract][Full Text] [Related]
18. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
